New Jersey Urology (NJU), a leading provider of urology and cancer care services, has announced the appointment of Dr. Chidebelu Ufodike as Chief Operating Officer. A nationally recognized healthcare leader, Dr. Ufodike brings over 25 years of experience in healthcare operations, pharmacy, and integrated care delivery to the role.
The addition of Dr. Ufodike comes at a time of continued growth for the practice, which operates more than 20 locations across central and southern New Jersey. Dr. Gordon A. Brown of New Jersey Urology expressed his enthusiasm for the new hire, citing Dr. Ufodike’s track record of managing complex delivery models.
“Dr. Ufodike’s passion for operational excellence makes him the perfect addition to our leadership team,” said Dr. Brown. “His focus on preserving excellent patient outcomes while expanding access to novel service lines will allow NJU to continue providing best-in-class care to patients throughout the region.”
Dr. Ufodike’s professional philosophy centers on creating robust infrastructures that allow medical professionals to focus on their primary mission: patient care.
“I am excited to join New Jersey Urology and partner with such an exceptional group of physicians and healthcare professionals,” said Dr. Ufodike. “Throughout my career, I’ve focused on building scalable operating models. I look forward to strengthening the infrastructure and capabilities that will ensure NJU continues to thrive as a leading urology platform.”
Before joining New Jersey Urology, Dr. Ufodike served as the Vice President of Pharmacy Inventory Management and Working Capital at Walgreens Boots Alliance. In this capacity, he:
-
Led enterprise initiatives for over 8,000 locations nationwide.
-
Managed more than $75 billion in pharmacy inventory.
-
Optimized supply chain capabilities and improved working capital performance for one of the largest healthcare retail networks in the country.
New Jersey Urology is one of the region’s premier urology practices, offering the latest treatments and technologies to the community. As an affiliate of U.S. Urology Partners—a network backed by General Atlantic—NJU remains dedicated to supporting community-based practices through clinical excellence and patient-centered care.
